Influenza Archives

Approvals News

Exploring Next-Gen Antivirals ft. Sam Lee, PhD, Co-CEO & President, Cocrystal Pharma – Xtalks Life Science Podcast Ep. 161

May 29, 2024

Biotech Blogs

Leaders in Flu Defense: Insights into the 2024/25 Influenza Vaccine Strategy

May 28, 2024

Biotech Blogs

New Trivalent Flu Vaccine for 2024/2025 and Other Insights from Leading Infectious Disease Experts Dr. Willliam Schaffner and Dr. Kelly Moore

May 10, 2024

Life Science Podcast

The State of Infectious Diseases: New Trivalent Flu Vaccine and More ft. Infectious Disease Experts Dr. William Schaffner and Dr. Kelly Moore – Xtalks Life Science Podcast Ep. 158

May 8, 2024

Infectious Disease Diagnostics for Influenza, RSV and SARS-CoV-2

March 05, 2024

Blogs

FDA Considers Self Administered Nasal Flu Vaccine + Wayne Gretzky Features in GSK RSV Vaccine Ad – Xtalks Life Science Podcast Ep. 135

November 8, 2023

Life Science Spotlight

What Challenges Is the Vaccine Industry Facing When Dealing with the Flu and COVID-19?

October 26, 2023

Biotech News

FluMist Nasal Flu Vaccine Gets FDA Consideration for Self-Administration

October 25, 2023

Approvals News

Lucira Gets FDA Authorization for First OTC At-Home Test for COVID-19 and Flu

March 8, 2023

Influenza

Baebies’ Finder Platform Secures Dual FDA Clearance and CLIA Waiver

Merck Bets on Flu Antiviral with $9.2B Acquisition of Cidara Therapeutics

How Can Rapid mRNA Quantification Enhance Multivalent Vaccine Development?

International Day of Epidemic Preparedness 2024: Amplifying Global Resilience

Polyrizon IPO Strengthens Momentum in Non-Invasive Drug Delivery Solutions

Innovative Approaches to Antiviral Drug Development

FluMist Takes Flu Protection Home: FDA Approves Self-Administration

Exploring Next-Gen Antivirals ft. Sam Lee, PhD, Co-CEO & President, Cocrystal Pharma – Xtalks Life Science Podcast Ep. 161

Leaders in Flu Defense: Insights into the 2024/25 Influenza Vaccine Strategy

New Trivalent Flu Vaccine for 2024/2025 and Other Insights from Leading Infectious Disease Experts Dr. Willliam Schaffner and Dr. Kelly Moore

The State of Infectious Diseases: New Trivalent Flu Vaccine and More ft. Infectious Disease Experts Dr. William Schaffner and Dr. Kelly Moore – Xtalks Life Science Podcast Ep. 158

Infectious Disease Diagnostics for Influenza, RSV and SARS-CoV-2

FDA Considers Self Administered Nasal Flu Vaccine + Wayne Gretzky Features in GSK RSV Vaccine Ad – Xtalks Life Science Podcast Ep. 135

What Challenges Is the Vaccine Industry Facing When Dealing with the Flu and COVID-19?

FluMist Nasal Flu Vaccine Gets FDA Consideration for Self-Administration

Lucira Gets FDA Authorization for First OTC At-Home Test for COVID-19 and Flu

To create an account, you will need to agree to the privacy policy and terms of use by clicking the agree button at the bottom of this form.

Privacy Policy

Baebies’ Finder Platform Secures Dual FDA Clearance and CLIA Waiver

Merck Bets on Flu Antiviral with $9.2B Acquisition of Cidara Therapeutics

How Can Rapid mRNA Quantification Enhance Multivalent Vaccine Development?

International Day of Epidemic Preparedness 2024: Amplifying Global Resilience

Polyrizon IPO Strengthens Momentum in Non-Invasive Drug Delivery Solutions

Innovative Approaches to Antiviral Drug Development

FluMist Takes Flu Protection Home: FDA Approves Self-Administration

Exploring Next-Gen Antivirals ft. Sam Lee, PhD, Co-CEO & President, Cocrystal Pharma – Xtalks Life Science Podcast Ep. 161

Leaders in Flu Defense: Insights into the 2024/25 Influenza Vaccine Strategy

New Trivalent Flu Vaccine for 2024/2025 and Other Insights from Leading Infectious Disease Experts Dr. Willliam Schaffner and Dr. Kelly Moore

The State of Infectious Diseases: New Trivalent Flu Vaccine and More ft. Infectious Disease Experts Dr. William Schaffner and Dr. Kelly Moore – Xtalks Life Science Podcast Ep. 158

Infectious Disease Diagnostics for Influenza, RSV and SARS-CoV-2

FDA Considers Self Administered Nasal Flu Vaccine + Wayne Gretzky Features in GSK RSV Vaccine Ad – Xtalks Life Science Podcast Ep. 135

What Challenges Is the Vaccine Industry Facing When Dealing with the Flu and COVID-19?

FluMist Nasal Flu Vaccine Gets FDA Consideration for Self-Administration

Lucira Gets FDA Authorization for First OTC At-Home Test for COVID-19 and Flu

Sign up for our newsletters and receive webinars, vitals and updates for your topic of choice.

To create an account, you will need to agree to the privacy policy and terms of use by clicking the agree button at the bottom of this form.

Privacy Policy